Document Detail


New directions in head and neck imaging.
MedLine Citation:
PMID:  18493943     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Computerized tomography (CT) and magnetic resonance imaging (MRI), positron emission tomography (PET) and the hybrid modality of PET/CT are sensitive and reliable tools for detection and staging of head and neck cancers. This article describes the role of PET/CT in initial staging of head and neck squamous cell carcinoma, the utility of CT/MR perfusion imaging in qualitative analysis of tumor tissue, and the usefulness of diffusion weighted MR and dynamic contrast-enhanced MR imaging in head and neck oncological imaging.
Authors:
Gaurang V Shah; Jeffery R Wesolowski; Sameer A Ansari; Suresh K Mukherji
Related Documents :
17043053 - Takayasu's arteritis--recent advances in imaging offer promise.
15764883 - Pet/ct imaging of conus medullaris metastasis from lung cancer.
10453393 - Estimation of the right ventricular volume and ejection fraction by transthoracic three...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Journal of surgical oncology     Volume:  97     ISSN:  0022-4790     ISO Abbreviation:  J Surg Oncol     Publication Date:  2008 Jun 
Date Detail:
Created Date:  2008-05-26     Completed Date:  2008-07-22     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0222643     Medline TA:  J Surg Oncol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  644-8     Citation Subset:  IM    
Copyright Information:
Copyright (c) 2008 Wiley-Liss, Inc.
Affiliation:
Department of Radiology, University of Michigan, Ann Arbor, Michigan 48109, USA. gvshah@med.umich.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Contrast Media / administration & dosage
Diagnostic Imaging / methods*,  trends
Fluorodeoxyglucose F18 / diagnostic use
Head and Neck Neoplasms / blood supply,  diagnosis*
Humans
Radiopharmaceuticals / diagnostic use
Chemical
Reg. No./Substance:
0/Contrast Media; 0/Radiopharmaceuticals; 63503-12-8/Fluorodeoxyglucose F18

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Current status of biomarkers in head and neck cancer.
Next Document:  Current status of FDG-PET for head and neck cancer.